+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Elimination of residual tumor cells from autologous bone marrow grafts by dye-mediated photolysis: preclinical data



Elimination of residual tumor cells from autologous bone marrow grafts by dye-mediated photolysis: preclinical data



Photochemistry and Photobiology 46(1): 71-76



MC540-mediated photolysis has several features that make it potentially attractive as a clinical purging procedure. (1) The experience with experimental tumors suggests that MC540-mediated photolysis is effective against a broad range of leukemias and solid tumors, including drug-resistant tumors (Sieber et al., 1984b). Drug-resistant tumor cells are likely to occur in heavily pretreated patients. (2) MC540-mediated photolysis is not cell-cycle dependent (Manna and Sieber, 1985). It kills both resting and cycling cells. In this regard, MC540-mediated photolysis is a valuable complement to cell-cycle specific cytotoxic drugs. (3) There is a large differential in sensitivity between normal pluripotent hematopoietic stem cells and leukemia and neuroblastoma cells. (4) The mechanism of action of MC540-mediated photolysis is different from that of lectins, antibodies and most cytotoxic drugs. MC540 binds to the lipid portion of the plasma membrane and membrane lipids are probably a primary target of the toxic photoproducts. Antibodies and lectins react with proteins and carbohydrates and most drugs have intracellular targets (e.g., nuclear DNA). We would therefore expect little cross-resistance if MC540-mediated photolysis were used in combination with other purging procedures.(5) The small amounts of dye that remain associated with the marrow graft and are infused into the patient are approximately 100,000-fold less than the LD(10) (in mice) and therefore unlikely to cause any harm. The outcome of the first clinical application of the technique supports this view (Sieber et al., 1986c). A better understanding of the underlying molecular mechanisms will undoubtedly lead to more effective applications of the technique and perhaps to the identification of more potent analogs of MC540.

(PDF emailed within 0-6 h: $19.90)

Accession: 040006430

Download citation: RISBibTeXText

PMID: 3303074

DOI: 10.1111/j.1751-1097.1987.tb04738.x


Related references

Elimination of residual tumor cells from autologous bone marrow grafts using monoclonal antibodies. Oldham, R K (Ed ) Principles Of Cancer Biotherapy X+502p Raven Press: New York, New York, Usa Illus 355-384, 1987

Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies. Nouvelle Revue Francaise D'hematologie 28(2): 97-105, 1986

Dye mediated photolysis of tumor cells implications for autologous bone marrow transplantation. Journal of Cellular Biochemistry Supplement (10 PART D): 220, 1986

Triarylmethane dyes as therapeutic agents for the photochemical purging of autologous bone marrow grafts from residual tumor cells. Biophysical Journal 78(1 Part 2): 256A, 2000

Elimination of residual acute myelogenous leukemia from autologous bone marrow grafts with in vitro chemotherapy. Leukemia Research 10(1): 88, 1986

Effect of molecular structure on the performance of triarylmethane dyes as therapeutic agents for photochemical purging of autologous bone marrow grafts from residual tumor cells. Journal of Pharmaceutical Sciences 89(1): 88-99, 2000

Residual leukemic cells in autologous marrow grafts do not significantly contribute to leukemia relapse after bone marrow transplantation. Experimental Hematology (Charlottesville) 16(6): 492, 1988

Immunomagnetic removal of residual tumor cells from human bone marrow prior to autologous bone marrow transplantation. Onkologie 14(SUPPL 2): 180, 1991

Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation. Blood 68(1): 32-36, 1986

Elimination of leukemic cells from autologous bone marrow grafts with antibody ricin conjugates. Experimental Hematology (Charlottesville) 11(SUPPL 14): 186, 1983

A simple elimination of clonogenic tumor cells from human bone marrow in vitro by heat: its application to autologous bone marrow transplantation for B-cell lymphoma. Annals of Hematology 64(6): 266-269, 1992

Elimination of tumor cells from marrow grafts by dye mediated photosensitization. Leukemia Research 10(1): 117, 1986

Detection and quantitation of genetically marked residual leukemia after autologous bone marrow transplantation A preclinical model for minimal residual disease. Blood 90(10 SUPPL 1 PART 1): 62A, Nov 15, 1997

The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts. Progress in Clinical and Biological Research 389: 601-609, 1994

Ischemic tissue repair by autologous bone marrow-derived stem cells: scientific basis and preclinical data. Handbook of Experimental Pharmacology: 167-179, 2007